Dhaval R. Mehta, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Mehta treats all types of cancer and has special interest in hematological disorders and solid tumors, and clinical trials in the community setting. Dr. Mehta is rated as an Advanced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Polycythemia Vera, Paget Disease of the Breast, Familial Pancreatic Cancer, and Neuroendocrine Tumor.

Khanh Nguyen, MD, specializes in medical oncology and practices with UPMC Hillman Cancer Center and is affiliated with UPMC East and UPMC Magee-Womens Hospital. Dr. Nguyen completed his medical education at the Medical College of Georgia and is board certified in Medical Oncology by the American Board of Internal Medicine. Dr. Nguyen is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, and Breast Cancer.

Nishant Tageja, MD, is a medical oncologist and hematologist. Dr. Tageja specializes in the treatment of solid tumors such as breast cancer, lung cancer, and colon cancer as well as treatment of all benign and malignant blood disorders including lymphoma, leukemia, and myeloma. Dr. Tageja is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Smoldering Multiple Myeloma, Non-Hodgkin Lymphoma, Familial Colorectal Cancer, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Transplant.

Valerie Wislo, MD, specializes in family medicine and is certified in family medicine by the American Board of Family Medicine. Dr. Wislo received her medical degree from the West Virginia University School of Medicine and completed her residency at UPMC St. Margaret.  Dr. Wislo’s clinical interests include treatment of opiate use disorder and the use of medical marijuana.  View the full list of Dr. Wislo’s publications on PubMed. Dr. Wislo is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her top areas of expertise are Myelodysplastic Syndrome (MDS) and Obesity in Children.

Anna Koget is a Hematologist Oncology specialist and an Oncologist in Pittsburgh, Pennsylvania. Dr. Koget is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her top areas of expertise are Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant.

Boriana Kamenova is a Hematologist Oncology specialist and a Hematologist in Monroeville, Pennsylvania. Dr. Kamenova is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her top areas of expertise are Inflammatory Breast Cancer, Breast Cancer, Anemia, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Kamenova is currently accepting new patients.

Jason Thomas is an Oncologist and a Hematologist in Monroeville, Pennsylvania. Dr. Thomas is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, Lung Cancer, and Pulmonary Embolism.

Prerna Mewawalla is a Hematologist Oncology specialist and a Hematologist in Pittsburgh, Pennsylvania. Dr. Mewawalla is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her top areas of expertise are Multiple Myeloma, Aplastic Anemia, Acute Myeloid Leukemia (AML), Bone Marrow Aspiration, and Bone Marrow Transplant.

Andrew D. Laman, MD, is a hematologist and oncologist at UPMC Hillman Cancer Center. Dr. Laman specializes in hematology and medical oncology. Dr. Laman is rated as an Advanced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, and Squamous Cell Lung Carcinoma.

James M. Rossetti, DO, is a hematologist specializing in the treatment of hematological malignancies and myeloid diseases, including myelodysplasia, acute myeloid leukemia, and myeloproliferative neoplasm. He also specializes in cellular therapy. Dr. Rossetti is a referral physician for the UPMC MDS Center of Excellence. Dr. Rossetti is rated as an Advanced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Acute Myeloid Leukemia (AML), Multiple Myeloma, Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant.

Jing-Zhou Hou, MD, PhD, is a clinical hematological oncologist specializing in hematological malignancies, cell therapy, and bone marrow transplant in the Mario Lemieux Center for Blood Cancers at UPMC Hillman Cancer Center. Dr. Hou received his medical degree from Henan Medical University in China, his master’s degree at Shanghai Medical University, and his PhD in Molecular and Cell Biology from Tulane University. He completed his internal medicine residency in Northeastern Ohio University College of Medicine, and fellowship in Hematology and Oncology at Stanford University. He joined UPMC Hillman Cancer Center in 2007. Dr. Hou is rated as an Advanced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant.

Stanley Marks, MD, specializes in hematology oncology and medical oncology and is board-certified in hematology and internal medicine by the American Board of Internal medicine. Dr. Marks completed his medical degree at the University of Pittsburgh School of Medicine. He completed his residency training at Presbyterian Hospital, and fellowship training in clinical medicine and research medicine at Peter Bent Brigham Hospital, Harvard Medical School and Dana Farber Cancer Center. He has received numerous awards including the Golden Apple Award for Outstanding Dedication to Housestaff Education from Allegheny General Hospital, Hillel Academy Outstanding Alumnus, and The Winged Victory of Samothrace Award from the Leukemia, Lymphoma Society of Western Pennsylvania. Dr. Marks is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Non-Hodgkin Lymphoma, Primary Lymphoma of the Brain, Gastric Lymphoma, and Follicular Lymphoma.

Dr. Kane has practiced for more than 20 years and is board certified in Medical Oncology. He received his medical degree from Ohio State University School of Medicine. He completed his residency training in Hematology/Oncology at the University of Pittsburgh School of Medicine. Dr. Kane is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Non-Hodgkin Lymphoma, Essential Thrombocythemia, Small Cell Lung Cancer (SCLC), and Familial Colorectal Cancer.

Jason Bierenbaum, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Bierenbaum specializes in lung cancer, gastrointestinal cancers, and myelodysplasia. Dr. Bierenbaum is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Small Cell Lung Cancer (SCLC), Familial Colorectal Cancer, Lung Cancer, and Pleuropulmonary Blastoma.

Hongmei Liang, MD, PhD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center at UPMC St. Margaret. Board certified in internal medicine and medical oncology, Dr. Liang received her medical degree from Shandong Medical University, Jinan in Shandong, China and PhD in immunology at the University of Pittsburgh School of Medicine. She completed her residency in internal medicine at Greater Baltimore Medical Center in Maryland and fellowship in hematology and oncology at the University of Pittsburgh Medical Center. Dr. Liang is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Childhood Iron Deficiency Anemia, and Pleuropulmonary Blastoma.

John Lech, DO, is a hematologist/medical oncologist at UPMC Hillman Cancer Center. He specializes in the treatment of gastrointestinal malignancies and peritoneal carcinomas. Dr. Lech is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Pleuropulmonary Blastoma.

Kelly G. Ross, MD, specializes in hematology oncology and is board-certified in hematolgoy and medical oncology by the American Board of Internal Medicine. She is affiliated with UPMC Shadyside and UPMC Presbyterian. Dr. Ross completed her fellowship at the University of Colorado and residency and medical degree at the University of Pittsburgh School of Medicine. Dr. Ross is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Mantle Cell Lymphoma (MCL), Bone Marrow Aspiration, and Bone Marrow Transplant.

Robert Redner is a Hematologist Oncology provider in Pittsburgh, Pennsylvania. Dr. Redner is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Acute Promyelocytic Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Redner is currently accepting new patients.

Alison Sehgal, MD, is an assistant professor of medicine at the University of Pittsburgh School of Medicine, and a hematologist/medical oncologist specializing in allogeneic and autologous stem cell transplant, lymphoma, leukemia, and multiple myeloma. Dr. Sehgal is conducting research in stem cell transplant and drug development in hematologic malignancies. Dr. Sehgal is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her top areas of expertise are Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), B-Cell Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.

Annie Im, MD, is an Associate Professor of Medicine at the University of Pittsburgh School of Medicine, and a hematologist/medical oncologist specializing and conducting research in hematologic malignancies (such as acute leukemia), drug development, stem cell transplantation, and graft-versus-host-disease. In addition, Dr. Im leads the chronic graft-versus-host-disease and stem cell transplant survivorship clinic. Dr. Im is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her top areas of expertise are Acute Myeloid Leukemia (AML), Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Bone Marrow Aspiration, and Bone Marrow Transplant.